SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Alan Turing

PatientAlan Turing
Date of birth1985-06-23
IdentifiersMRN HR-ML007-SYN; SSN (made up) 000-07-6290
Document date2026-04-14
AuthorRupert Hallam, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New-patient primary care visit for breast enlargement, low libido, and low mood after a year of high-dose estrogen given without his consent [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
31 March 1952Year of oestrogen treatment (probably stilboestrol) accepted as the alternative to prison after his conviction for gross indecencyD (CLM-0003, CLM-0004)
1952Breast growth attributed to the hormone treatment, which he is known to have mentioned onceD (CLM-0005)
November 1952Decided to see a psychiatrist again and began Jungian analysisD (CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cholecalciferol 1,000 units (25 mcg) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-04-14activeS

Review of Systems

Positive for the concerns in the history of present illness. Tall, lean, casually dressed; slightly hesitant speech that becomes quick and precise on technical subjects; wry humor; cooperative. Mood "flattened, and angry about what was done to me"; affect constricted, reactive; thought process linear; no suicidal ideation, intent, or plan; no psychotic features; insight and judgment good. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. At intake, working full days but sleeping badly, avoiding the running club changing room, and seeing friends less. [S]

Physical Exam

Vital signs recorded on 2026-04-14; see the Vital Signs section. Mental status: Tall, lean, casually dressed; slightly hesitant speech that becomes quick and precise on technical subjects; wry humor; cooperative; Mood "flattened, and angry about what was done to me"; affect constricted, reactive; thought process linear; no suicidal ideation, intent, or plan; no psychotic features; insight and judgment good. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Structured safety assessment: current ideation absent, intent absent, plan absent, access to means reviewed: yes. Outpatient care with a collaborative safety plan, the 988 Suicide & Crisis Lifeline, and a two-week follow-up. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-04-14Body height178cmS
2026-04-14Body weight71.4kgS
2026-04-14Body mass index (BMI) [Ratio]22.5kg/m2S
2026-04-14Systolic blood pressure122mm[Hg]S
2026-04-14Diastolic blood pressure76mm[Hg]S
2026-04-14Heart rate64/minS
2026-04-14Respiratory rate14/minS
2026-04-14Body temperature36.6CelS
2026-04-14Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]15{score}S
2026-04-14Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]8{score}S
2026-04-14Total score [AUDIT-C]2{score}S
2026-04-14Testosterone [Mass/volume] in Serum or Plasma112ng/dL264-916 ng/dLLowS
2026-04-14Estradiol (E2) [Mass/volume] in Serum or Plasma148pg/mL7.6-42.6 pg/mLHighS
2026-04-14Lutropin [Units/volume] in Serum or Plasma0.3m[IU]/mL1.7-8.6 m[IU]/mLLowS
2026-04-14Follitropin [Units/volume] in Serum or Plasma0.4m[IU]/mL1.5-12.4 m[IU]/mLLowS
2026-04-14Sex hormone binding globulin [Moles/volume] in Serum or Plasma88nmol/L16.5-55.9 nmol/LHighS
2026-04-14Prolactin [Mass/volume] in Serum or Plasma21.6ng/mL4-15.2 ng/mLHighS
2026-04-14Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma1m[IU]/mL<=3 m[IU]/mLNormalS
2026-04-14Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma2.6ng/mL<=8.3 ng/mLNormalS
2026-04-14Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-55 U/LNormalS
2026-04-14Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L8-48 U/LNormalS
2026-04-14Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-04-14Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.74-1.35 mg/dLNormalS
2026-04-14Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M102mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-14Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4 mIU/LNormalS
2026-04-14Hemoglobin [Mass/volume] in Blood13g/dL13.2-16.6 g/dLLowS
2026-04-1425-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma22ng/mL30-100 ng/mLLowS

Problems

ProblemClinical statusVerificationCodeProvenance
Bilateral gynecomastia, tender, about 4 cm of firm glandular tissue behind each nipple, after a year of high-dose estrogen; synthetic modern diagnosis linked to the documented breast growth from his hormone treatmentactiveconfirmed N62S — Synthetic modern diagnosis. That the hormone treatment caused breast growth is reported in the sources (D, mentioned once in his own words); the examination findings are synthetic.
Suppressed testosterone and gonadotropins from exogenous estrogen (drug-induced hypogonadotropic hypogonadism), with low libido, erectile difficulty, and fatigueactiveconfirmed E23.1S — Synthetic consequence of high-dose estrogen, which suppresses LH and FSH; recovery is expected once it stops.
Adverse effects of high-dose estrogen given for a year without free and informed consent, as the alternative to imprisonmentactiveconfirmed T38.5X5AS — Synthetic modern framing of the documented hormone treatment imposed after his conviction (D); in the modern episode it is recorded as iatrogenic harm.
Major depressive disorder, single episode, moderate, after prosecution and coerced hormone treatment; synthetic modern diagnosis (no depression diagnosis is documented in his lifetime)activeconfirmed F32.1S — Synthetic modern diagnosis. That he sought Jungian analysis after the trial is documented (D); calling his state then a depressive illness is a retrospective interpretation (R).
Vitamin D insufficiency (25-hydroxyvitamin D 22 ng/mL)activeconfirmed E55.9S — Synthetic finding of the bone-health workup.

Assessment

Plan of Treatment